Canada markets closed

Serina Therapeutics, Inc. (SER)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
8.14-0.66 (-7.50%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 20.36M
Enterprise Value 19.83M
Trailing P/E 17.05
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-59.66%
S&P500 52-Week Change 326.27%
52 Week High 335.71
52 Week Low 38.10
50-Day Moving Average 311.87
200-Day Moving Average 317.91

Share Statistics

Avg Vol (3 month) 35.39k
Avg Vol (10 day) 32.56k
Shares Outstanding 52.5M
Implied Shares Outstanding 62.5M
Float 8890.08k
% Held by Insiders 156.07%
% Held by Institutions 11.57%
Shares Short (Apr 30, 2024) 45.47k
Short Ratio (Apr 30, 2024) 41.75
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.17%
Shares Short (prior month Mar 28, 2024) 44.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 228:1000
Last Split Date 3Mar 15, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 167.11%
Operating Margin (ttm)7.81%

Management Effectiveness

Return on Assets (ttm)-39.79%
Return on Equity (ttm)594.21%

Income Statement

Revenue (ttm)3.15M
Revenue Per Share (ttm)1.38
Quarterly Revenue Growth (yoy)5,258.50%
Gross Profit (ttm)N/A
EBITDA -3.04M
Net Income Avi to Common (ttm)5.27M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.62M
Total Cash Per Share (mrq)3.09
Total Debt (mrq)3.69M
Total Debt/Equity (mrq)89.88%
Current Ratio (mrq)5.39
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-2.48M
Levered Free Cash Flow (ttm)-1.82M